1. Home
  2. LILAK vs IVA Comparison

LILAK vs IVA Comparison

Compare LILAK & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liberty Latin America Ltd. Class C

LILAK

Liberty Latin America Ltd. Class C

N/A

Current Price

$7.77

Market Cap

1.7B

ML Signal

N/A

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

N/A

Current Price

$6.52

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LILAK
IVA
Founded
2017
2011
Country
Bermuda
France
Employees
N/A
84
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
LILAK
IVA
Price
$7.77
$6.52
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$8.20
$16.20
AVG Volume (30 Days)
716.9K
381.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.37
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.23
$2.70
52 Week High
$9.13
$7.98

Technical Indicators

Market Signals
Indicator
LILAK
IVA
Relative Strength Index (RSI) 44.68 57.06
Support Level $7.60 $5.79
Resistance Level $8.53 $7.17
Average True Range (ATR) 0.38 0.31
MACD -0.03 -0.04
Stochastic Oscillator 19.77 54.43

Price Performance

Historical Comparison
LILAK
IVA

About LILAK Liberty Latin America Ltd. Class C

Liberty Latin America Ltd is a telecommunications company. It is a provider of video, broadband internet, fixed-line telephony, and mobile services to residential and business customers. The company's reportable segments include C&W Caribbean, Liberty Networks, C&W Panama, VTR, Liberty Puerto Rico and Liberty Costa Rica. The company generates the majority of its revenue from C&W Caribbean, and Liberty Puerto Rico segments.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: